Full Text View
Tabular View
No Study Results Posted
Related Studies
3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors
This study has been completed.
Study NCT00079014   Information provided by National Cancer Institute (NCI)
First Received: March 8, 2004   Last Updated: May 19, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Interventions listed in this trial
doxorubicin hydrochloride
triapine
Additional drug interventions recognized in this trial
Doxorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Wisconsin, Madison
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services